Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Hepatology 2012 (546 pages, free PDF)
Hepatitis C 2012 (150 pages, free PDF)

Free Medical Books

  Gynecology

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    May 2012
  1. BERNS EM , Bowtell DD
    The Changing View of High-Grade Serous Ovarian Cancer.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



  2. REN H , Tan ZP, Zhu X, Crosby K, et al
    Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



  3. IMAYAMA I , Ulrich CM, Alfano CM, Wang C, et al
    Effects of a Caloric Restriction Weight Loss Diet and Exercise on Inflammatory Biomarkers in Overweight/Obese Postmenopausal Women: A Randomized Controlled Trial.
    Cancer Res. 2012;72:2314-2326.
    PubMed     Text format     Related articles    Abstract available



  4. MATEI D , Fang F, Shen C, Schilder J, et al
    Epigenetic Resensitization to Platinum in Ovarian Cancer.
    Cancer Res. 2012;72:2197-2205.
    PubMed     Text format     Related articles    Abstract available



    April 2012
  5. HO GY , Wang T, Gunter MJ, Strickler HD, et al
    Adipokines Linking Obesity with Colorectal Cancer Risk in Postmenopausal Women.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



  6. LIN JH , Morikawa T, Chan AT, Kuchiba A, et al
    Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



    March 2012

  7. Correction: Significance of MAD2 Expression to Mitotic Checkpoint Control in Ovarian Cancer Cells.
    Cancer Res. 2012.
    PubMed     Text format     Related articles   



  8. JULIN B , Wolk A, Bergkvist L, Bottai M, et al
    Dietary cadmium exposure and risk of postmenopausal breast cancer: a population-based prospective cohort study.
    Cancer Res. 2012;72:1459-66.
    PubMed     Text format     Related articles    Abstract available



  9. CHEN X , Thiaville MM, Chen L, Stoeck A, et al
    Definition of NOTCH3 target genes in ovarian cancer.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



  10. XIAO K , Li Y, Lee JS, Gonik AM, et al
    "OA02" Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



  11. BAI L , McEachern D, Yang CY, Lu J, et al
    LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFalpha expression and receptor tyrosine kinase signaling.
    Cancer Res. 2012;72:1229-38.
    PubMed     Text format     Related articles    Abstract available



    February 2012
  12. CUBILLOS-RUIZ JR , Baird JR, Tesone AJ, Rutkowski MR, et al
    Reprogramming tumor-associated dendritic cells in vivo using microRNA mimetics triggers protective immunity against ovarian cancer.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



    January 2012
  13. WHITE KL , Schildkraut JM, Palmieri RT, Iversen ES, et al
    Ovarian Cancer Risk Associated with Inherited Inflammation-Related Variants.
    Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



  14. LI N , Kaur S, Greshock J, Lassus H, et al
    A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer.
    Cancer Res. 2012;72:154-64.
    PubMed     Text format     Related articles    Abstract available



    December 2011
  15. ARORA HC , Jensen MP, Yuan Y, Wu A, et al
    Nanocarriers Enhance Doxorubicin Uptake in Drug-Resistant Ovarian Cancer Cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  16. KULBE H , Chakravarty P, Leinster DA, Charles KA, et al
    A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  17. OBERMAJER N , Muthuswamy R, Odunsi KO, Edwards R, et al
    PGE2-Dependent CXCL12 Production and CXCR4 Expression Control the Accumulation of Human MDSCs in Ovarian Cancer Environment.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  18. MURATA T , Mizushima H, Chinen I, Moribe H, et al
    HB-EGF and PDGF Mediate Reciprocal Interactions of Carcinoma Cells with Cancer-Associated Fibroblasts to Support Progression of Uterine Cervical Cancers.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  19. SOMMARIVA M , De Cecco L, De Cesare M, Sfondrini L, et al
    TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.
    Cancer Res. 2011;71:6382-90.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  20. YEW CW , Lee P, Chan WK, Lim VK, et al
    A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  21. GUAN B , Wang TL, Shih IM
    ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  22. STEFANSKA B , Huang J, Bhattacharyya B, Suderman M, et al
    Definition of the landscape of promoter DNA hypomethylation in liver cancer.
    Cancer Res. 2011;71:5891-903.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  23. TSURUTA T , Kozaki KI, Uesugi A, Furuta M, et al
    miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  24. BITLER BG , Nicodemus JP, Li H, Cai Q, et al
    Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  25. HUBERT P , Heitzmann A, Viel S, Nicolas A, et al
    Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy.
    Cancer Res. 2011;71:5134-43.
    PubMed     Text format     Related articles    Abstract available



  26. SWAMINATHAN V , Mythreye K, O'Brien ET, Berchuck A, et al
    Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines.
    Cancer Res. 2011;71:5075-80.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  27. REBBECK TR , Mitra N, Domchek SM, Wan F, et al
    Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1 Interacting Genes.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  28. DARSHAN MS , Loftus MS, Thadani-Mulero M, Levy BP, et al
    Taxane-Induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  29. HU W , Lu C, Han HD, Huang J, et al
    Biological roles of the Delta family notch ligand Dll4 in tumor and endothelial cells in ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  30. FUCIKOVA J , Kralikova P, Fialova A, Brtnicky T, et al
    Human tumor cells killed by anthracyclines induce a tumor-specific immune response.
    Cancer Res. 2011;71:4821-33.
    PubMed     Text format     Related articles    Abstract available



  31. RIGHI E , Kashiwagi S, Yuan J, Santosuosso M, et al
    CXCL12/CXCR4 blockade induces multimodal anti-tumor effects and prolongs survival of immunocompetent mice with ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  32. POLYTARCHOU C , Iliopoulos D, Hatziapostolou M, Kottakis F, et al
    Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation.
    Cancer Res. 2011;71:4720-31.
    PubMed     Text format     Related articles    Abstract available



  33. SONG DG , Ye Q, Carpenito C, Poussin M, et al
    In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB).
    Cancer Res. 2011;71:4617-27.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  34. LABIDI-GALY SI , Sisirak V, Meeus P, Gobert M, et al
    Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  35. KONSTANTINOPOULOS PA , Spentzos D, Fountzilas E, Francoeur N, et al
    Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  36. BAJAJ J , Maliekal TT, Vivien E, Pattabiraman C, et al
    Notch signaling in CD66+ cells drives the progression of human cervical cancers.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  37. HUEHLS AM , Wagner JM, Huntoon CJ, Geng L, et al
    Poly(ADP-ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  38. STRONACH EA , Alfraidi AM, Rama NR, Datler C, et al
    HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  39. SILVA IA , Bai S, McLean K, Yang K, et al
    Aldehyde dehydrogenase and CD133 define angiogenic ovarian cancer stem cells that portend poor patient survival.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  40. PERMUTH-WEY J , Kim D, Tsai YY, Lin HY, et al
    LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



  41. URICK ME , Rudd ML, Godwin AK, Sgroi DC, et al
    PIK3R1 (p85-alpha/p85{alpha}) is Somatically Mutated at High Frequency in Primary Endometrial Cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  42. RUDNICK SI , Lou J, Shaller CC, Tang Y, et al
    Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors.
    Cancer Res. 2011;71:2250-9.
    PubMed     Text format     Related articles    Abstract available



  43. SYED N , Coley HM, Sehouli J, Koensgen D, et al
    Polo-like kinase PLK 2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: